The high-stakes nature of cancer care, coupled with rapid scientific advancements and increasing payer and regulatory pressures, demands a specialized approach beyond traditional market access strategies.
Shana Gunderson Hua, PharmD; Nancy Pham, PharmD; and Pete Vaccaro
Advertisement
Articles by Shana Gunderson Hua, PharmD; Nancy Pham, PharmD; and Pete Vaccaro
Advertisement
Latest Updated Articles
Oncology Brands Face Uniquely Complex Market Access Challenges: A Specialized Approach for Commercial SuccessPublished: March 28th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Novo Nordisk’s Unsolicited Proposal to Acquire Metsera
3
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
4
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
5
